<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医业观察 | wechat-feeds</title><link>http://MzI5MjUxMTY0OA.favicon.privacyhide.com/favicon.ico</link><description>关注IVD行业趋势，有观点、有态度，6万IVD人已关注，原创超过380篇。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 07 Apr 2021 13:27:35 +0800</pubDate><image><url>http://MzI5MjUxMTY0OA.favicon.privacyhide.com/favicon.ico</url><title>医业观察 | wechat-feeds</title><link>http://MzI5MjUxMTY0OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>你好，Triage！让我来看看你有多快</title><link>https://mp.weixin.qq.com/s/2axNeEhZKAS9oG_QEho6eQ</link><description></description><content:encoded><![CDATA[你好，Triage！让我来看看你有多快]]></content:encoded><pubDate>Tue, 06 Apr 2021 23:23:48 +0800</pubDate></item><item><title>原料-产品-市场趋势，全方位分析重庆CACLP</title><link>https://mp.weixin.qq.com/s/V9tSbmcd1SBUI9grEzUnWw</link><description></description><content:encoded><![CDATA[原料-产品-市场趋势，全方位分析重庆CACLP]]></content:encoded><pubDate>Tue, 06 Apr 2021 23:23:48 +0800</pubDate></item><item><title>海外收入要占70% ！迈瑞医疗全球业务计划公布</title><link>https://mp.weixin.qq.com/s/Lqq5dAdE9vIDYctPcp1DuA</link><description></description><content:encoded><![CDATA[海外收入要占70% ！迈瑞医疗全球业务计划公布]]></content:encoded><pubDate>Tue, 06 Apr 2021 23:23:48 +0800</pubDate></item><item><title>国内首个获批！幽门螺杆菌23S rRNA基因突变检测试剂盒（PCR-荧光探针法）</title><link>https://mp.weixin.qq.com/s/5jugUWZsXSn0pZVQCSRDpw</link><description></description><content:encoded><![CDATA[国内首个获批！幽门螺杆菌23S rRNA基因突变检测试剂盒（PCR-荧光探针法）]]></content:encoded><pubDate>Tue, 06 Apr 2021 23:23:48 +0800</pubDate></item><item><title>新型超快速核酸分子诊断国产荧光PCR仪：百泰克BTK-8！</title><link>https://mp.weixin.qq.com/s/6MDwMiqW4n2GN1oAwymkeQ</link><description></description><content:encoded><![CDATA[新型超快速核酸分子诊断国产荧光PCR仪：百泰克BTK-8！]]></content:encoded><pubDate>Tue, 06 Apr 2021 17:20:08 +0800</pubDate></item><item><title>厉害了，微策喜获MDSAP认证，一次审核满足5国法规要求</title><link>https://mp.weixin.qq.com/s/LqcdVRkJ0lDyNueSFTjMXw</link><description></description><content:encoded><![CDATA[厉害了，微策喜获MDSAP认证，一次审核满足5国法规要求]]></content:encoded><pubDate>Tue, 06 Apr 2021 17:20:08 +0800</pubDate></item><item><title>重庆CACLP会感想-产品篇——全面与创新</title><link>https://mp.weixin.qq.com/s/9KCddVEgRT8uCUMpbpmH9w</link><description></description><content:encoded><![CDATA[重庆CACLP会感想-产品篇——全面与创新]]></content:encoded><pubDate>Tue, 06 Apr 2021 17:20:08 +0800</pubDate></item><item><title>重庆CACLP会感想-感观篇——重庆IVD与CACLP现场</title><link>https://mp.weixin.qq.com/s/YKZIc6UYsHs3XEhdmkh0qQ</link><description></description><content:encoded><![CDATA[重庆CACLP会感想-感观篇——重庆IVD与CACLP现场]]></content:encoded><pubDate>Tue, 06 Apr 2021 17:20:08 +0800</pubDate></item><item><title>一场慢病管理行业饭局有感：快和跨界思维</title><link>https://mp.weixin.qq.com/s/byya9oV1AOydqkHdhdwjYw</link><description></description><content:encoded><![CDATA[一场慢病管理行业饭局有感：快和跨界思维]]></content:encoded><pubDate>Mon, 05 Apr 2021 22:11:33 +0800</pubDate></item><item><title>CACLP观展感受（一）：产品</title><link>https://mp.weixin.qq.com/s/9zQiUS7f2t91g58adsMtDQ</link><description></description><content:encoded><![CDATA[CACLP观展感受（一）：产品]]></content:encoded><pubDate>Mon, 05 Apr 2021 22:11:33 +0800</pubDate></item><item><title>CACLP观展感受（二）：跨界</title><link>https://mp.weixin.qq.com/s/F3e_tUzo59CjccJIh0ISWg</link><description></description><content:encoded><![CDATA[CACLP观展感受（二）：跨界]]></content:encoded><pubDate>Mon, 05 Apr 2021 22:11:33 +0800</pubDate></item><item><title>你都不在圈子里，还想发财？</title><link>https://mp.weixin.qq.com/s/nW6phSi6EQQqZ3Ns7Uw7PQ</link><description></description><content:encoded><![CDATA[你都不在圈子里，还想发财？]]></content:encoded><pubDate>Sun, 04 Apr 2021 21:35:26 +0800</pubDate></item><item><title>一次策划活动只花了10万，回款470万，IVD产品还能这么卖！</title><link>https://mp.weixin.qq.com/s/fiU-dRO3e31vUg6w9fQTeQ</link><description></description><content:encoded><![CDATA[一次策划活动只花了10万，回款470万，IVD产品还能这么卖！]]></content:encoded><pubDate>Sun, 04 Apr 2021 21:35:26 +0800</pubDate></item><item><title>奥泰生物：2021CACLP圆满结束</title><link>https://mp.weixin.qq.com/s/H2Jn3yhiYFVBWQx7opvwFA</link><description></description><content:encoded><![CDATA[奥泰生物：2021CACLP圆满结束]]></content:encoded><pubDate>Sun, 04 Apr 2021 21:35:26 +0800</pubDate></item><item><title>为什么医疗行业的老板不太分钱？</title><link>https://mp.weixin.qq.com/s/SHntMeutte0r6MHXw71EsA</link><description></description><content:encoded><![CDATA[为什么医疗行业的老板不太分钱？]]></content:encoded><pubDate>Sat, 03 Apr 2021 16:03:56 +0800</pubDate></item><item><title>狂招3000人！康华生物的腾飞绝非偶然</title><link>https://mp.weixin.qq.com/s/uYMakknDZcw4cC6-3S_XDg</link><description></description><content:encoded><![CDATA[狂招3000人！康华生物的腾飞绝非偶然]]></content:encoded><pubDate>Sat, 03 Apr 2021 16:03:56 +0800</pubDate></item><item><title>何以获得罗氏青睐？深度解析分子诊断优等生GenMark</title><link>https://mp.weixin.qq.com/s/Uwq0IBeo-u4ND29z5ckmJw</link><description></description><content:encoded><![CDATA[何以获得罗氏青睐？深度解析分子诊断优等生GenMark]]></content:encoded><pubDate>Sat, 03 Apr 2021 16:03:56 +0800</pubDate></item><item><title>CACLP观感：全自动、智能化、多联检，1188家IVD企业的军备竞赛</title><link>https://mp.weixin.qq.com/s/Gr1PUjnUp2rVeyG6Oah8eg</link><description></description><content:encoded><![CDATA[CACLP观感：全自动、智能化、多联检，1188家IVD企业的军备竞赛]]></content:encoded><pubDate>Fri, 02 Apr 2021 20:59:07 +0800</pubDate></item><item><title>超1亿美元，世界500强丹纳赫再度加码中国！</title><link>https://mp.weixin.qq.com/s/LQTBwVMFZNswF12xQ1LLyA</link><description></description><content:encoded><![CDATA[超1亿美元，世界500强丹纳赫再度加码中国！]]></content:encoded><pubDate>Fri, 02 Apr 2021 20:59:07 +0800</pubDate></item><item><title>哥斯拉大战金刚-IVD后疫情时代漫谈（上）</title><link>https://mp.weixin.qq.com/s/Jnr_sUtRB2rCl2rPhs8eRg</link><description></description><content:encoded><![CDATA[哥斯拉大战金刚-IVD后疫情时代漫谈（上）]]></content:encoded><pubDate>Fri, 02 Apr 2021 20:59:07 +0800</pubDate></item></channel></rss>